Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population

Xiao Q, Liu ZJ, Tao S, Sun YM, Jiang D, Li HL, Chen H, Liu X, Lapin B, Wang CH, Zheng SL, Xu J, Wu ZY.

Oncotarget. 2015 Nov 10;6(35):36955-64. doi: 10.18632/oncotarget.6271.

Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology

Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, Macaulay SL, Wilson W, Darby DG, Martins RN, Ames D, Collins S, Silbert B, Masters CL, Doecke JD; AIBL Research Group.

Alzheimers Res Ther. 2015 Nov 19;7(1):71. doi: 10.1186/s13195-015-0157-7.

Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease

Rommer PS, Fuchs D, Leblhuber F, Schroth R, Greilberger M, Tafeit E, Greilberger J.

Neurodegener Dis. 2016;16(3-4):284-9. doi: 10.1159/000441565. Epub 2015 Nov 21.

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study

Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P, Vrenken H, van der Flier WM.

Neuroimage Clin. 2015 Sep 9;9:418-29. doi: 10.1016/j.nicl.2015.08.022. eCollection 2015.

What is the potential of dried matrix spot sampling for cerebrospinal fluid analysis?

Hirtz C, Lehmann S.

Bioanalysis. 2015;7(22):2849-51. doi: 10.4155/bio.15.201. Epub 2015 Nov 13.

Alzheimer's disease: Unique markers for diagnosis & new treatment modalities

Aggarwal NT, Shah RC, Bennett DA.

Indian J Med Res. 2015 Oct;142(4):369-82. doi: 10.4103/0971-5916.169193.

The New Conceptualization of Alzheimer's Disease under the Microscope of Influential Definitions of Disease

Alexopoulos P, Kurz A.

Psychopathology. 2015;48(6):359-67. doi: 10.1159/000441327. Epub 2015 Nov 27.

Is amyloid-β harmful to the brain? Insights from human imaging studies

Jagust W.

Brain. 2016 Jan;139(Pt 1):23-30. doi: 10.1093/brain/awv326. Epub 2015 Nov 27.

Alzheimer's disease lymphocytes: potential for biomarkers?

Wojda U.

Biomark Med. 2016;10(1):1-4. doi: 10.2217/bmm.15.79. Epub 2015 Dec 7.

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field

Shams S, Wahlund LO.

Biomark Med. 2016;10(1):9-18. doi: 10.2217/bmm.15.101. Epub 2015 Dec 7.

Paradigm shift: semantic memory decline as a biomarker of preclinical Alzheimer's disease

Venneri A, Mitolo M, De Marco M.

Biomark Med. 2016;10(1):5-8. doi: 10.2217/bmm.15.53. Epub 2015 Dec 7.

Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease

Ali R, Goubran M, Choudhri O, Zeineh MM.

Neurosurg Focus. 2015 Nov;39(5):E4. doi: 10.3171/2015.9.FOCUS15326.

Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman FC.

Mol Cell Proteomics. 2016 Feb;15(2):409-25. doi: 10.1074/mcp.R115.053330. Epub 2015 Dec 11.

Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients

Hatanaka H, Hanyu H, Fukasawa R, Hirao K, Shimizu S, Kanetaka H, Iwamoto T.

Geriatr Gerontol Int. 2015 Dec;15 Suppl 1:53-8. doi: 10.1111/ggi.12659.

Toward more predictive genetic mouse models of Alzheimer's disease

Onos KD, Sukoff Rizzo SJ, Howell GR, Sasner M.

Brain Res Bull. 2016 Apr;122:1-11. doi: 10.1016/j.brainresbull.2015.12.003. Epub 2015 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias